
Surge in EG.5 Subvariant of COVID-19: Recognizing the Symptoms
Cases of the Eris subvariant (EG.5) of COVID-19 have increased and now account for 29.4% of cases in the US, making it the most prevalent subvariant. The World Health Organization has confirmed cases in 71 countries, with the highest percentages in the US, China, Japan, South Korea, Canada, and the UK. While EG.5 has shown increased prevalence and immune escape properties, there have been no reported changes in disease severity. Symptoms of Eris include runny nose, sneezing, cough, nausea, sore throat, fatigue, headache, muscle aches, and changes to or loss of sense of smell and taste.

